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Abstract
Background: Little is known about vascular access conversion and outcomes for patients starting hemodialysis
with nonfunctional arteriovenous (AV) access. We assessed mortality risk associated with nonfunctional AV access at
hemodialysis initiation, taking subsequent changes in vascular access into account.
Methods: We studied the 53,092 incident adult hemodialysis patients included in the French REIN registry from
2005 through 2012. AV access placed predialysis was considered nonfunctional when dialysis began with a central
venous catheter. Information about vascular access changes was obtained from treatment modality updates.
Results: At hemodialysis initiation, AV access was functional for 47% of patients and nonfunctional for 9%; 44% had
a catheter alone. After a 3-year follow-up, 63% of patients beginning hemodialysis with a nonfunctional AV access
had changed to a functional one, 4% had had a transplant, 19% had died before any vascular access change, and
13% still used a catheter. Cox proportional hazard models with vascular access treated as a time-dependent variable
showed an adjusted mortality hazard ratio (95% confidence interval) for patients with nonfunctional AV access who
subsequently converted to functional access of 0.95 (95% CI 0.89–1.03) compared with the reference group with
functional AV access since first hemodialysis, versus 1.43 (95% CI 1.31–1.55) for those who did not convert.
Conclusions: Among patients starting hemodialysis with a nonfunctional AV access, a substantial percentage may
never experience successful vascular access conversion. Poor survival seems to be limited to these patients, while those
who subsequently convert to functional AV access have similar mortality risk compared to patients with such access
since hemodialysis initiation. Every effort should be made to obtain functional AV access in all suitable patients.
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Background
Survival of hemodialysis patients is strongly related to
the type of vascular access. Numerous studies have
shown that arteriovenous (AV) access (either fistulae or
grafts) is associated with lower mortality [1–4] and fewer
morbid events [5, 6] than central venous catheters.
Guidelines for vascular access agree that AV access is
the best option for hemodialysis patients, but there is no
consensus about the optimal timing for creation, espe-
cially for AV fistulae [7–9]. Hence, AV access use at
hemodialysis initiation does not come close to meeting
current therapeutic goals [10]. Only 18% of US patients
start hemodialysis with functional AV access, and this
rate does not exceed 30 to 45% in Europe [2, 3, 11, 12].
The lack of functionality of a significant number of AV
fistulae and grafts created before hemodialysis initiation
results in initial catheter use. Nonfunctionality rates of
about 18% are reported among the overall populations
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of incident hemodialysis patients in Canada and the US
[2–4]. Rates as high as 45% have been observed in
elderly patients with predialysis AV fistula creation [13].
Because of differences in patient selection and practices
for AV access placement [14–16], nonfunctionality rates,
their determinants, and outcomes may differ between
Europe and North America. Only a few studies have in-
vestigated outcomes when AV access was nonfunctional
at hemodialysis initiation, all of them in North America
[2, 3, 13]. They report that survival is poorer with a non-
functional than functional AV access and worst with
catheters alone [2, 3]. High rates of vascular access con-
version in patients starting dialysis with a nonfunctional
AV access may explain their better outcome, as sug-
gested by studies in patients who started with a catheter
and subsequently converted to a functional AV access
[17–19]. Nonetheless, considering outcomes specifically
after hemodialysis initiation with nonfunctional AV
access is important in the context of the current Fistula
First Catheter Last initiative, which seeks to increase the
use of AV fistulae in patients in whom they are deemed
feasible [20]. We therefore used data from the French
Renal Epidemiology and Information Network (REIN)
registry to study changes of vascular access in patients
starting hemodialysis with a nonfunctional AV access
and the impact on outcome in a setting with relatively
high AV access use.
Methods
Population
The French REIN registry includes all patients on renal
replacement therapy (RRT) for end-stage renal disease
(ESRD) – either dialysis or transplantation. It began in
2002 and progressively expanded to include the entire
country in 2011. Details on methods and quality control
of the REIN registry have been described elsewhere [21].
In this study, we considered the 55,847 patients who
started hemodialysis from 2005 through 2012. After ex-
cluding minors (n = 370) and patients with missing vas-
cular access data (n = 2385), we classified the remaining
53,092 patients according to their vascular access at
hemodialysis initiation and by 2 data items (Fig. 1): 1/
“indicate if the vascular access at the first dialysis session
was a catheter”: “yes/no”; 2/“date of first AV access
placement, even if it is not functional at dialysis initi-
ation”: “day/month/year”. When the vascular access at
the first hemodialysis session was not a catheter, patients
were classified as having functional AV access, regardless
of reported creation date (n = 25,153, with missing dates
for 3855). The remaining 27,939 patients who started
hemodialysis with a catheter were divided into 2 groups
according to the date of AV access creation: when the
date preceded hemodialysis initiation, patients were con-
sidered to have nonfunctional AV access (n = 4705); if
the date was after hemodialysis initiation (9030) or was
Fig. 1 Cohort selection. Abbreviation: AV arteriovenous
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not reported (14,204), patients were considered to have
started hemodialysis with a catheter alone (n = 23,234).
AV fistulae and AV grafts cannot be distinguished at
hemodialysis initiation, but in 2013 only 3% of prevalent
patients in France had grafts [12].
Outcomes
Patients were followed up for mortality, kidney trans-
plantation, peritoneal dialysis switch, and dialysis
weaning until December 31, 2013. Information about
vascular access changes was obtained from modality
treatment updates or annual updates in the REIN
registry, which report any permanent change (excluding
one-off changes) and specify the type of AV access (fistu-
lae or grafts).
Statistical analyses
Patient characteristics at baseline were described and
compared between 3 groups defined by the type of vas-
cular access at hemodialysis initiation, as described
above: functional AV access, nonfunctional AV access,
and catheter alone. Because of missing data for some
variables (Table 1), we performed multiple imputation of
20 datasets with the fully conditional specification
method [22, 23]. The imputation model included all var-
iables in Table 1, as well as geographic region, year of
first ESRD treatment, and vital status at the end of
follow-up. Analyses through the 20 complete datasets
were combined according to Rubin and Schencker’s
rules. We studied crude survival with the Kaplan-Meier
method and compared the 3 vascular access groups by
the log-rank test. We then used the cumulative incident
function, with Gray’s test, to estimate rates of conversion
to functional AV access over 3 years, as well as those of
renal transplantation, peritoneal dialysis switch, dialysis
weaning, or death (whichever came first) as competing
events, in patients who began hemodialysis with non-
functional AV access or catheter alone [24]. We also es-
timated adjusted odds ratios for lack of vascular access
conversion associated with patients’ characteristics in
these two subgroups. Finally, we used Cox proportional
hazard models to estimate crude and sequentially ad-
justed cause-specific mortality hazard ratios (HRs) and
95% confidence intervals (95%CI) associated with non-
functional AV access (or catheter alone) at baseline,
compared with functional AV access. HRs were first
adjusted for demographic variables (age, gender, year of
RRT initiation, and geographic region), then for clinical
variables (comorbidities and laboratory values over the
1-month period before RRT), and finally for predialysis
treatment with erythropoiesis-stimulating agents, dialysis
start condition (planned or unplanned), and facility char-
acteristics. A final model included vascular access as a
time-dependent variable, which means that, for each
death, the Cox model compared the current vascular
access of patient(s) who died at time t to that of all other
patients who were at risk, i.e., alive on hemodialysis at
that time [25].
Because changes in vascular access were not dated,
but reported within update intervals, we hypothesized
that they occurred at the midpoint of each update inter-
val. We also restricted analysis to patients followed up at
least 3 months because of the uncertainty about vascular
access change reports in patients dying within the first
3 months of hemodialysis. Mortality rates per 1000
person-years were thus calculated considering the begin-
ning of follow-up at 3 months. Conversions to functional
AV access within the first 3 months were however taken
into account for patients included in this analysis. We
carried out 2 sensitivity analyses: one using the end
instead of the midpoint of each update interval for vas-
cular access, and other limiting the analysis to patients
with at least one annual update (84% of the study popu-
lation). The proportional hazard assumption was
assessed by plotting scaled Schoenfeld residuals versus
rank time. Log-linearity was assessed for continuous
variables. Two-sided significance tests were used and
P-values <0.05 were considered significant. Robust
variance estimates were used to account for facility clus-
tering effects. All statistical analyses were performed
with SAS 9.4 (SAS Institute Inc, Cary, NC).
Results
Patients’ median age was 71 (IQR, 59–79) years, 63%
were men, 40% had diabetes and 30% at least 2 cardio-
vascular comorbidities. Dialysis start was unplanned for
33%. Overall, 44% started dialysis with a catheter alone,
and 56% after predialysis AV access placement: 47% were
functional and 9% nonfunctional. The percentage of
patients with predialysis AV access placement decreased
significantly from 60% in 2005 to 54% in 2012 (P-value
for trend <0.001) while that of nonfunctional AV access
remained stable. Table 1 summarizes patient characteris-
tics according to vascular access type at the start of
hemodialysis.
Changes in vascular access
The median follow-up was 3 years (range 1–9 years).
Most patients (96%) had updated vascular access infor-
mation in the first 3 months of hemodialysis; 91, 88, and
84% had updated information in the first, second, and
third year of follow-up, respectively. Overall, 75% of
patients alive on hemodialysis at 12 months had func-
tional AV access, 81% at 24 months, and 84% at
36 months. These percentages were lower for patients
with nonfunctional AV access at baseline than for those
with functional AV access, but higher than for patients
with catheter alone (Additional file 1). Of note, between
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Table 1 Patient characteristics according to vascular access at hemodialysis initiation
Characteristics Functional AV access Nonfunctional AV access Catheter only Imputed missing
data (%)n = 25,153 n = 4705 n = 23,234
Men 65.0 58.2 62.0 0
Age (years, median (IQR)) 70.4 (58.2–78.6) 70.6 (59.6–78.9) 72.0 (59.6–80.3) 0
Primary renal disease
Hypertensive/Vascular 27.3 26.5 25.4
Diabetic nephropathy 23.1 30.9 21.4
Glomerulonephritis 12.0 9.1 9.6 0
Polycystic kidney disease 9.7 4.5 2.3
Other 16.6 17.9 26.2
Unknown 11.2 11.1 15.3
Diabetes 38.5 49.0 39.8 1.5
Number of cardiovascular comorbidities
0 48.8 40.1 40.9
1 25.5 26.3 24.6
2 15.1 17.5 18.4 5.8
3 7.5 10.9 11.0
4 or 5 3.1 5.2 5.2
Lower limb amputation 2.3 4.3 4.3 5.6
Malignancy 8.2 9.5 15.1 3.1
Mobility status
Autonomous 87.1 79.5 72.2
Needs assistance 9.9 14.9 18.8 13.6
Totally dependent 3.0 5.7 9.1
Body mass index (kg/m2)
<18.5 4.7 5.5 8.0
[18.5–25.0] 40.9 38.4 44.6 26.4
[25.0–30.0] 32.5 30.6 28.9
≥30.0 21.9 25.5 18.4
Serum albumin (g/l, mean ± SD) 35.0 ± 5.9 32.5 ± 6.2 30.9 ± 6.4 43.9
Hemoglobin (g/dl, mean ± SD) 10.6 ± 1.6 10.1 ± 1.7 9.7 ± 1.8 21.0
Predialysis ESA treatment 59.2 55.0 31.1 9.7
Estimated glomerular filtration rate (MDRD ml/min/1.73 m2)
eGFR≤5 8.7 13.2 17.7
5<eGFR≤10 53.9 52.8 47.4
10<eGFR≤15 28.9 25.3 23.9 17.4
15<eGFR≤20 6.7 6.4 7.3
eGFR>20 1.8 2.3 3.6
Unplanned dialysis start 9.5 37.7 56.9 2.8
Facility type
In center 92.0 96.9 98.3
Satellite unit 4.0 1.5 1.0 0
Self-dialysis 4.0 1.6 0.7
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2 and 3% of patients classified with functional AVF actu-
ally had a functional AV graft at these time points, with
no significant difference among groups. At the end of
follow-up, 3075 (65.4%) and 10,156 (43.7%) patients in
the nonfunctional AV access group and catheter-only
group, respectively, have had at least one conversion to
functional AV access. The cumulative incidence of vas-
cular access conversion, with death and renal transplant-
ation treated as competing events, was higher in patients
with nonfunctional AV access at hemodialysis initiation
than in those with catheters alone. Patients with catheter
alone at dialysis initiation were nearly twice as likely to
die before any reported conversion to functional AV ac-
cess as those starting dialysis with nonfunctional AV
access (Fig. 2a and b). Factors associated with lack of
conversion to functional AV access in patients with
either nonfunctional AV access or catheter only at base-
line are shown in Table 2. Overall, patients who did not
convert to a functional AV access were older, most often
women, and had poorer health condition. However, the
effect of age, malignancy, and poor mobility status on
the lack of access conversion appeared to be stronger in
patients with catheter only as compared to those with
nonfunctional AV access at baseline.
Mortality associated with nonfunctional AV access
During the study period, 22,635 (43%) patients died (of
whom 3419 within the first three months of dialysis),
7935 (15%) had kidney transplantation, and 19,100 (36%)
remained on hemodialysis. Other outcomes included
switch to peritoneal dialysis (3%), dialysis weaning (3%),
and loss to follow-up (1%). Kaplan-Meier curves com-
paring the three vascular access groups at hemodialysis
initiation showed survival was best in the functional AV
access group, intermediate in the nonfunctional AV
access group, and poorest in the catheter alone group
(log-rank P-value <0.0001; Additional file 2). Cox pro-
portional hazard models showed that the excess risk
associated with nonfunctional AV access at hemodialysis
initiation was strongly attenuated after adjustment for
clinical factors, but remained a significant 10% higher
after full adjustment (Additional file 3). The risk of death
was lower for patients with nonfunctional AV access
than for the catheter alone group. After changes in
vascular access were considered, the mortality risk of
patients with nonfunctional AV access who subsequently
acquired functional access was similar to that of patients
whose AV access was functional from the start (Fig. 3).
Patients starting dialysis with a catheter alone had the
highest risk of death when they continued with a cath-
eter, and the lowest risk if they subsequently acquired a
functional AV access. Hazard ratios were stable over
time as indicated by the Schoenfeld residual plot (data
not shown) Sensitivity analyses using the end instead of
the midpoint of each update interval for vascular access
or limiting the analysis to patients with at least one an-
nual update did not materially alter these findings
(Table 3).
Discussion
This study shows that in France, where the rate of
predialysis AV access placement is relatively high,
nonfunctional AV access at hemodialysis initiation is
common and does not appear to have decreased over
time. A substantial percentage of patients with nonfunc-
tional AV access at first hemodialysis may never acquire
a functional AV access which is associated with in-
creased mortality risk. In contrast, the outcome of
patients with a nonfunctional AV access converting to a
functional one appears similar to that of those starting
with a functional AV access. These findings have import-
ant implications for clinical practice and public health
policies.
The 9% frequency of nonfunctional AV access at
hemodialysis initiation in our study is of the same order
of magnitude as that reported in Canada (9%) [4], but
lower than in the US (18%) [2, 3]. Nevertheless, the rela-
tive weight of nonfunctional AV accesses among all
those created predialysis was much lower in France than
in North America. About 16% of patients with predialy-
sis AV access started hemodialysis with a catheter in
France, while this percentage was 33% in Canada and
about 50% in the US. The Dialysis Outcomes and
Practice Patterns Study (DOPPS) has pointed out several
differences in both patient characteristics and clinical
practices between Europe and North America that may
explain this discrepancy. For instance, hemodialysis
patients in North America have more comorbidities than
Table 1 Patient characteristics according to vascular access at hemodialysis initiation (Continued)
Facility ownership
Public university 17.9 27.3 30.9
Public non-university 29.8 31.7 31.6
Private for-profit 34.0 30.3 28.8 0
Private not-for-profit 18.4 10.7 8.8
Abbreviations: AV arteriovenous, CI confidence interval, IQR interquartile range, SD standard deviation, ESA erythropoiesis-stimulating agents, MDRD Modification of
Diet in Renal Disease. P values of the comparisons between the 3 groups were statistically significant at <0.0001 for every characteristic in Table 1
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those in Europe [26], and these are well established
determinants of poor AV access use and patency [27, 28].
Most striking, however, are the differences in practices.
Not only are rates of AV access at hemodialysis initiation in
Europe substantially higher than in North America [14, 29],
but surgical training has been shown to differ between
these 2 regions, and more training with AV access, as found
in Europe, is associated with both AV access creation and
patency [30]. Once an AV access is placed, the involvement
of the access surgeon in monitoring it for maturation and
functional use or in planning for another access in case of
failure may impact functionality rates. Nevertheless, infor-
mation is lacking about the relationship of the access
surgeon to the dialysis patient after AV access is placed.
Earlier AV fistula cannulation in European countries [14]
may also partly explain the lower prevalence of nonfunc-
tional AV access in our study.
As expected, nonfunctional AV access at hemodialysis
initiation was associated with an increase of 10% in over-
all mortality risk, compared with functional AV access.
Since AV fistulae account for 97% of the AV access in
France, this increased risk is lower than the 30% excess
mortality associated with maturing compared with
mature AV fistulae observed in all US adult patients who
started dialysis between 2006 and 2010 [3]. This excess
mortality risk was even higher in elderly patients in the
Fig. 2 Cumulative incidence# of vascular access conversion to functional AV access. (a) Nonfunctional AV access group and (b) Catheter only
group at hemodialysis initiation. #Competing risks considered were renal transplantation, peritoneal dialysis switch, dialysis weaning, and death,
whichever came first. Gray’s test P-value (nonfunctional AV access versus catheter only): conversion to functional AV access, peritoneal dialysis
switch, dialysis weaning, and death, <0.0001; renal transplantation, 0.04. Abbreviation: AV arteriovenous. *Cumulative incidence of peritoneal
dialysis and dialysis weaning in the nonfunctional AV access group: 0.8 and 0.7%, respectively
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Table 2 Patient characteristics associated with lack of conversion to functional AV access in patients starting hemodialysis with
nonfunctional AV access or with catheter only
Characteristics Vascular access at baseline P-value for interactiona
Nonfunctional AV access Catheter only
aOR (95% CI) P-value aOR (95% CI) P-value
Women 1.25 (1.10–1.43) 0.0009 1.28 (1.20–1.36) <0.0001 0.9514
Age (1-year increase) 1.01 (1.01–1.02) <0.0001 1.02 (1.01–1.02) <0.0001 0.0117
Primary renal disease 0.5615 <0.0001 0.0938
Hypertensive/Vascular 0.94 (0.73–1.22) 0.93 (0.83–1.04)
Diabetic nephropathy 0.94 (0.71–1.25) 0.84 (0.74–0.95)
Glomerulonephritis
Polycystic kidney disease 1.11 (0.76–1.61) 0.79 (0.64–0.97)
Other 1.13 (0.87–1.47) 1.19 (1.07–1.33)
Unknown 1.00 (0.75–1.34) 1.15 (1.03–1.29)
Diabetes 0.92 (0.77–1.10) 0.3405 0.99 (0.92–1.07) 0.8856 0.6441
Number of cardiovascular comorbidities 0.0008 <0.0001 0.4444
0
1 1.19 (1.01–1.40) 1.12 (1.04–1.21)
2 1.27 (1.04–1.54) 1.39 (1.28–1.52)
3 1.45 (1.16–1.82) 1.58 (1.42–1.75)
4 or 5 2.09 (1.55–2.82) 1.88 (1.63–2.17)
Lower limb amputation 1.13 (0.73–1.74) 0.5884 1.26 (1.07–1.47) 0.0050 0.3740
Malignancy 1.23 (0.99–1.52) 0.0592 1.65 (1.51–1.79) <0.0001 0.0056
Mobility status <0.0001 <0.0001 0.0105
Autonomous
Needs assistance 1.41 (1.17–1.69) 1.61 (1.48–1.74)
Totally dependent 2.05 (1.55–2.70) 2.90 (2.56–3.28)
Body mass index (kg/m2) 0.9333 0.0003 0.0856
<18.5 1.03 (0.73–1.47) 1.21 (1.07–1.36)
[18.5–25.0]
[25.0–30.0] 1.01 (0.86–1.19) 0.96 (0.89–1.03)
≥30.0 1.03 (0.86–1.23) 0.85 (0.78–0.94)
Serum albumin (1-g/l increase) 0.99 (0.98–1.01) 0.3773 0.99 (0.99–1.00) 0.0033 0.2750
Anemia (hemoglobin <10 g/dl) 0.95 (0.83–1.10) 0.5156 0.91 (0.85–0.97) 0.0027 0.6696
Predialysis ESA treatment 1.12 (0.98–1.27) 0.0899 1.04 (0.97–1.11) 0.3031 0.3383
Estimated glomerular filtration rate (MDRD ml/min/1.73 m2) 0.0037 <0.0001 0.9829
eGFR≤5 0.68 (0.54–0.86) 0.75 (0.68–0.83)
5<eGFR≤10 0.88 (0.74–1.03) 0.91 (0.84–0.99)
10<eGFR≤15
15<eGFR≤20 1.11 (0.83–1.48) 1.19 (1.04–1.37)
eGFR>20 1.38 (0.90–2.12) 1.35 (1.13–1.60)
Facility type 0.0001 0.0001 0.3805
In center
Satellite unit 0.37 (0.19–0.73) 0.59 (0.42–0.82)
Self-dialysis 0.28 (0.14–0.57) 0.48 (0.35–0.65)
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US [2]. Discrepancies in mortality risk estimates associ-
ated with nonfunctional AV access at hemodialysis initi-
ation between the 2 countries may, however, reflect
differences in the rate of conversion to functional AV
access after dialysis initiation, as our findings suggest.
The availability of updated vascular access status during
follow-up in the REIN registry enabled us to determine
that patients with nonfunctional AV access at hemodialysis
initiation had lower rates of functional AV access during
the first 3 years of RRT than patients who started with
functional AV access, but higher rates than patients who
started with catheter alone. Our results indicate that the ex-
cess mortality risk in patients starting hemodialysis with a
catheter, either because no AV access was placed or because
it was nonfunctional, is limited to patients who remained
on dialysis with a catheter. Thus, once a permanent vascu-
lar access was in place for patients with nonfunctional AV
access at initiation, their mortality risk was similar to those
with functional AV access at first dialysis. Nevertheless, des-
pite adjusting for several potential confounders, we cannot
completely rule out a selection effect, with healthier indi-
viduals chosen for AV access conversion, as an explanation
of the better outcome of this subgroup of patients. Such a
selection effect is at least partly indicated by the overall
poorer health condition of patients who did not convert to
a functional AV access, notably in the catheter only group.
Moreover, patients with a catheter alone at baseline and
subsequent functional AV access had the lower mortality
risk among the studied groups.
These findings, however, are consistent with those from
DOPPS, which showed that in patients initiating dialysis
with a catheter, conversion to a permanent AV access was
associated with an adjusted mortality HR of 0.69 (95% CI,
0.55–0.85) [18]. Similarly, the HEMO study showed no
difference in mortality risk between patients with long-
term AV access versus those who converted from catheter
in the preceding year of treatment [17]. Likewise, in preva-
lent dialysis patients treated in Fresenius Medical Care
facilities, catheter conversion to AV access within a
4-month period was associated with a mortality risk in the
following 8 months similar to that of patients with AV
access from the outset of the follow-up [19].
Our finding that survival was similar in patients with
functional AV access after hemodialysis initiation, re-
gardless of their vascular access at the start, should not
be interpreted as calling into question the fistula first
Table 2 Patient characteristics associated with lack of conversion to functional AV access in patients starting hemodialysis with
nonfunctional AV access or with catheter only (Continued)
Facility ownership 0.0790 0.1452 0.6509
Public university
Public non-university 0.77 (0.66–0.91) 0.82 (0.76–0.89)
Private for-profit 0.78 (0.66–0.92) 0.79 (0.73–0.85)
Private not-for-profit 1.11 (0.88–1.40) 0.94 (0.85–1.05)
aP-value for interaction between patient characteristic and AV access at baseline. ORs were adjusted for year of hemodialysis initiation and for all variables in
Table 2. Abbreviations: aOR adjusted odds ratio, CI confidence interval, AV arteriovenous, ref reference, ESA erythropoiesis-stimulating agents, MDRD Modification
of Diet in Renal Disease
Fig. 3 Adjusted mortality hazard ratios associated with baseline vascular access taking subsequent changes into account. Patients with a follow-up shorter
than 3 months were excluded. The model was adjusted for all variables in Table 1 as well as region, year of hemodialysis initiation, and vascular access
changes as time dependent variable. *Mortality rate per 1000 patient-years. Abbreviations: AV arteriovenous, HR hazard ratio, CI confidence interval
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principle. In our study, only 63% of patients with non-
functional AV access at initiation converted to a func-
tional one. Moreover, the catheter use itself may have
prevented conversion to a functional access for some
patients: catheter use is associated with mortality risk,
and some patients may have had catheter-related early
deaths. Moreover, catheter use may contribute to subse-
quent AV access failure due to central venous stenosis
[5, 31, 32]. Given that AV fistulae may never be success-
ful for some fraction of patients because of their poor
vascular condition, the potential of AV grafts for
reducing catheter use should be considered. Studies in
the US have shown similar outcomes for AV fistulae and
AV grafts in some subpopulations [33, 34].
Major strengths of this study include the size and un-
selected nature of our registry-based population, which
enable generalization of our results to France and other
European countries having similar context. In addition,
we were able to take major potential confounders into
account in the multivariate analyses, including numerous
comorbidities and treatment conditions. Lastly, updated
information on vascular access was available, and very
few patients were lost to follow-up.
Our study also has limitations. First, the prevalence of
nonfunctional AV access may be underestimated due to
missing AV creation dates. Because the presence of AV
access itself at start is not recorded, but only its date of
creation if any, we do not know how many patients
among those with no reported creation date had no AV
access and how many had a missing date for AV access
creation. The percentage of missing dates is known,
however, for patients who started with functional AV ac-
cess (15%). Simulation of missing date rates showed that
their potential impact on the prevalence estimate of
nonfunctional AV access would be low: for example,
10% instead of 9%, if the missing date rate was 15% for
both the functional and nonfunctional AV access groups,
and 13%, if this rate was twice as high (30%) for the non-
functional access group. Second, available data did not
allow to specify whether the nonfunctional access was
patent but not sufficiently matured, or failed and not
salvageable. Finally, the vascular access update was
interval-censored, which may have resulted in misclassi-
fication. Nevertheless, sensitivity analysis using the end
of each interval provided consistent findings. Moreover,
because annual updates in the REIN registry concern
patients’ permanent treatment, our data are likely to
reflect outcomes associated with long-term use of a
given vascular access.
Conclusion
In France with its relatively high rate of predialysis AV
access creation, AV access is nonfunctional at
hemodialysis initiation for a substantial percentage of
patients. Importantly, conversion to functional AV access
in patients who started on catheter is associated with
similar mortality risk as compared to that of patients
with functional AV access from the beginning. However,
the reasons why a significant number of predialysis AV
accesses never become functional require further investi-
gation to identify potentially modifiable risk factors.
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Table 3 Sensitivity analyses
Sensitivity analyses : Setting changes
at the end of the
interval
Limiting population to
those with at least one
annual update
Vascular access group HR (95% CI)
Functional AV access
unchanged 1 1




1.05 (0.97–1.13) 0.98 (0.91–1.06)




1.02 (0.96–1.08) 0.90 (0.84–0.95)
unchanged 1.53 (1.45–1.61) 1.94 (1.83–2.06)
Patients with a follow-up shorter than 3 months were excluded. The model
was adjusted for all variables in Table 1 as well as region, year of hemodialysis
initiation, and vascular access changes as time dependent variable.
Abbreviations: AV arteriovenous, HR hazard ratio,
CI confidence interval
Adjusted mortality hazard ratios associated with initial vascular access taking
subsequent changes into account
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